Swedbank’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303M | Buy |
2,819,249
+1,505,019
| +115% | +$162M | 0.34% | 65 |
|
|
2025
Q1 | $133M | Buy |
1,314,230
+35,300
| +3% | +$3.56M | 0.18% | 112 |
|
|
2024
Q4 | $114M | Sell |
1,278,930
-151,995
| -11% | -$13.6M | 0.14% | 119 |
|
|
2024
Q3 | $120M | Buy |
1,430,925
+8,246
| +0.6% | +$691K | 0.15% | 117 |
|
|
2024
Q2 | $110M | Buy |
+1,422,679
| New | +$110M | 0.15% | 118 |
|
|
2024
Q1 | – | Sell |
-1,562,755
| Closed | -$90.3M | – | 600 |
|
|
2023
Q4 | $90.3M | Sell |
1,562,755
-14,576
| -0.9% | -$843K | 0.15% | 124 |
|
|
2023
Q3 | $83.3M | Buy |
1,577,331
+33,383
| +2% | +$1.76M | 0.14% | 121 |
|
|
2023
Q2 | $83.5M | Buy |
1,543,948
+106,651
| +7% | +$5.77M | 0.14% | 122 |
|
|
2023
Q1 | $71.9M | Buy |
1,437,297
+28,960
| +2% | +$1.45M | 0.14% | 136 |
|
|
2022
Q4 | $65.2M | Buy |
1,408,337
+296,054
| +27% | +$13.7M | 0.14% | 141 |
|
|
2022
Q3 | $43.1M | Buy |
1,112,283
+383,566
| +53% | +$14.9M | 0.1% | 182 |
|
|
2022
Q2 | $27.2M | Buy |
728,717
+460,772
| +172% | +$17.2M | 0.06% | 253 |
|
|
2022
Q1 | $11.9M | Buy |
267,945
+4,395
| +2% | +$195K | 0.02% | 420 |
|
|
2021
Q4 | $11.3M | Hold |
263,550
| – | – | 0.02% | 443 |
|
|
2021
Q3 | $11.4M | Buy |
263,550
+216
| +0.1% | +$9.37K | 0.02% | 446 |
|
|
2021
Q2 | $11.3M | Buy |
263,334
+6,842
| +3% | +$293K | 0.02% | 461 |
|
|
2021
Q1 | $9.91M | Buy |
+256,492
| New | +$9.91M | 0.02% | 467 |
|